Yuan Zhi's Stock Ratings

B. Riley Securities Analyst

Yuan Zhi is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

78.0%

Smart Score

71.9%

Overall Average Return Percentile

98th

Number of Ratings

24
Buy NowGet Alert
05/15/2024CTSOBuy Now
CytoSorbents
$0.90233.3% → $3ReiteratesBuy → BuyGet Alert
05/03/2024CYRXBuy Now
CryoPort
$9.9291.61%$22 → $19DowngradeBuy → NeutralGet Alert
04/09/2024CATXBuy Now
Perspective Therapeutics
$1.4120.57%$1.2 → $1.7MaintainsBuyGet Alert
03/20/2024FUSNBuy Now
Fusion Pharmaceuticals
$21.566.68%$13 → $23DowngradeBuy → NeutralGet Alert
03/18/2024AGENBuy Now
Agenus
$15.60-67.95%$120 → $100MaintainsBuyGet Alert
02/01/2024AZTABuy Now
Azenta
$50.5156.4%$61 → $79MaintainsBuyGet Alert
01/26/2024CATXBuy Now
Perspective Therapeutics
$1.41-14.89% → $1.2Initiates → BuyGet Alert
01/09/2024AMAMBuy Now
Ambrx Biopharma
——$26 → $28DowngradeBuy → NeutralGet Alert
12/11/2023ATNMBuy Now
Actinium Pharma
$8.1596.32%$20 → $16MaintainsBuyGet Alert
12/08/2023TNGXBuy Now
Tango Therapeutics
$6.92131.21% → $16Initiates → BuyGet Alert
10/03/2023FUSNBuy Now
Fusion Pharmaceuticals
$21.56-39.7% → $13ReiteratesBuy → BuyGet Alert
10/03/2023ATNMBuy Now
Actinium Pharma
$8.15145.4% → $20ReiteratesBuy → BuyGet Alert
07/13/2023CYRXBuy Now
CryoPort
$9.92121.87%$30 → $22MaintainsBuyGet Alert
06/14/2023AMAMBuy Now
Ambrx Biopharma
—— → $26Initiates → BuyGet Alert
03/30/2023FUSNBuy Now
Fusion Pharmaceuticals
$21.56-53.62% → $10Reiterates → BuyGet Alert
02/21/2023ISEEBuy Now
IVERIC bio
——$17 → $19MaintainsNeutralGet Alert
02/10/2023AZTABuy Now
Azenta
$50.5134.63%$77 → $68MaintainsBuyGet Alert
12/01/2022FUSNBuy Now
Fusion Pharmaceuticals
$21.56-53.62% → $10Reinstates → BuyGet Alert
11/16/2022CYRXBuy Now
CryoPort
$9.92202.54%$55 → $30MaintainsBuyGet Alert
10/31/2022ATNMBuy Now
Actinium Pharma
$8.15120.86%$16 → $18MaintainsBuyGet Alert
09/06/2022ISEEBuy Now
IVERIC bio
——$12 → $8DowngradeNeutral → SellGet Alert
08/25/2022ATNMBuy Now
Actinium Pharma
$8.1596.32% → $16Initiates → BuyGet Alert
05/17/2022AZTABuy Now
Azenta
$50.5186.1%$106 → $94MaintainsBuyGet Alert
05/12/2022ISEEBuy Now
IVERIC bio
—— → $12Initiates → NeutralGet Alert

Recent Analyst Stock Rating News

Coinbase Global To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Friday
Stem Reports Downbeat Results, Joins Sprout Social, Cloudflare And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Analyst Ratings For CryoPort
Decoding 7 Analyst Evaluations For Azenta
In-Depth Examination Of 5 Analyst Recommendations For Azenta
A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts
Assessing Ambrx Biopharma: Insights From 7 Financial Analysts
A Closer Look at 4 Analyst Recommendations For Fusion Pharmaceuticals
Foxconn's Huawei Unit Workers Are Cashing Bigger Paychecks Than iPhone Assemblers
The report states that Foxconn's FIH unit oversees Huawei smartphone production and has been offering better compensation to the new workers in Shenzhen's Longhua district.
Nvidia Chief Flags Dangers To US Chips Act, Disney, Shell, Gucci Allegedly Used Worthless Carbon Credits, Microsoft's Daring Attempt to Outshine Google In Search Game: Today's Top Stories
Benzinga
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free